Sheila Jacobs

Contributing Writer https://www.infectiousdiseaseadvisor.com

Sheila Jacobs is the president of STJ Editorial Services. For more than 25 years, Sheila has been providing writing, fact-checking, and editorial services to numerous clients in the medical education, promotional, and managed care arenas, from the conceptual stage through completion of the final editorial product. Her focus has been in a diverse array of therapeutic areas.

All articles by Sheila Jacobs

Respiratory

Normal Dose Moxifloxacin Maintained Effectiveness in Rifampin-Resistant TB

Sheila Jacobs

March 9, 2020

A short, 9-month regimen of normal dose moxifloxacin maintained good effectiveness up to 24 months after therapy cessation in patients with rifampicin-resistant tuberculosis.

Respiratory

Elderly Patients Able to Complete Latent Tuberculosis Therapy

Sheila Jacobs

October 1, 2019

Treatment for latent tuberculosis infection among patients between age 65 and 78 years has been shown to be relatively well tolerated, with completion rates decreasing according to age.

GI Illness

Sensitization to S aureus Enterotoxins May Increase Risk for Severe Asthma

Sheila Jacobs

August 12, 2019

Sensitization to Staphylococcus aureus enterotoxins was linked to an increased subsequent risk for severe asthma and asthma exacerbations.

Diagnostics

Latent TB Detection: QuantiFERON-TB Gold Plus vs QuantiFERON-TB Gold In-Tube

Sheila Jacobs

May 23, 2019

Positive results with respect to the presence of latent tuberculosis infection in patients with renal failure were more consistent with the use of QuantiFERON-TB Gold Plus testing compared with the use of QuantiFERON-TB Gold In-Tube testing.

Hepatitis Advisor

Hepatitis D Treatment: Peginterferon Alfa-2a + Tenofovir Disoproxil Fumarate

Sheila Jacobs

May 17, 2019

Researchers found data that showed that patients with hepatitis D virus did not benefit by combination therapy with tenofovir disoproxil fumarate and peginterferon alfa-2a, concluding that alternative therapies are needed.

Hepatitis Advisor

Risk for Liver Cancer Associated With HCV-Induced Epigenetic Changes

Sheila Jacobs

May 16, 2019

Researchers found evidence in a genome-wide study that to prevent liver cancer among patients who have been treated for hepatitis C virus infection the sphingosine kinase 1 oncogene should be targeted.

Prevention

Assessing Pneumococcal Vaccine Immunogenicity in Systemic Lupus Erythematosus

Sheila Jacobs

March 1, 2019

Researchers conducted a post hoc analysis on antipneumococcal antibody responses in patients with SLE previously immunized with the 23-valent pneumococcal polysaccharide vaccine.